Celgene Corporation

CELG 
(NASDAQ) 
 
$ 93.76 <%= Resources.Global.txtDown %>
Updated 17/04/2019
Change % -0.57% Stock price decreasing
Change -0.54 Stock price decreasing
Volume 6,212,459
High $ 94.69
Low $ 93.32
Open $ 94.67
ISIN
Prev close $ 94.30
# of shares 702.45M
Market cap 65,862M USD
Intraday

Market closed
Celgene Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  93.76 -0.4% Stock price decreasing 4.6% Stock price increasing 8.7% Stock price increasing 13.8% Stock price increasing 5.4% Stock price increasing
Powered by TradingView

News about Celgene Corporation

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Bristol-Myers Squibb Company 45.52 -0.1% Stock price decreasing -7.0% Stock price decreasing -9.2% Stock price decreasing -16.2% Stock price decreasing -11.0% Stock price decreasing -12.4% Stock price decreasing
 
Johnson & Johnson 137.52 1.1% Stock price increasing -0.4% Stock price decreasing 5.2% Stock price increasing -1.1% Stock price decreasing 8.6% Stock price increasing 6.6% Stock price increasing
 
Merck & Company Inc (new) 73.19 -7.9% Stock price decreasing -11.8% Stock price decreasing -3.5% Stock price decreasing 1.2% Stock price increasing 24.4% Stock price increasing -4.2% Stock price decreasing
 
Pfizer Inc 39.38 -5.6% Stock price decreasing -7.0% Stock price decreasing -7.4% Stock price decreasing -11.5% Stock price decreasing 7.5% Stock price increasing -9.8% Stock price decreasing
 
Amgen Inc 177.47 -7.3% Stock price decreasing -7.5% Stock price decreasing -13.0% Stock price decreasing -12.1% Stock price decreasing 3.4% Stock price increasing -8.8% Stock price decreasing
 
Gilead Sciences Inc 62.95 -3.6% Stock price decreasing -3.0% Stock price decreasing -9.0% Stock price decreasing -14.1% Stock price decreasing -14.6% Stock price decreasing 0.6% Stock price increasing
 
Vertex Pharmaceuticals Incorpo.. 168.16 -8.0% Stock price decreasing -7.9% Stock price decreasing -13.6% Stock price decreasing -4.3% Stock price decreasing 6.3% Stock price increasing 1.5% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 5,815.00 -2.9% Stock price decreasing -10.9% Stock price decreasing 3.1% Stock price increasing -2.0% Stock price decreasing 16.9% Stock price increasing -1.0% Stock price decreasing
 
Novartis AG 76.41 -4.8% Stock price decreasing -18.4% Stock price decreasing -14.1% Stock price decreasing -12.4% Stock price decreasing -1.9% Stock price decreasing -11.0% Stock price decreasing
 
Takeda PHARM.CO.LTD. 32.00 -4.9% Stock price decreasing -14.7% Stock price decreasing -11.0% Stock price decreasing -10.2% Stock price decreasing -13.1% Stock price decreasing 10.6% Stock price increasing
 
Biogen Inc 226.39 -3.5% Stock price decreasing -0.2% Stock price decreasing -32.9% Stock price decreasing -29.3% Stock price decreasing -13.9% Stock price decreasing -24.8% Stock price decreasing
 
Roche Hldg Sp.Adr 1/8 28.54 -3.7% Stock price decreasing -3.7% Stock price decreasing 1.4% Stock price increasing 8.7% Stock price increasing 26.4% Stock price increasing 10.5% Stock price increasing

Company profile

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Peers

Instruments Last Change  
Bristol-Myer.. 45.52 -0.6% Stock price decreasing
Johnson & Jo.. 137.52 -0.7% Stock price decreasing
Merck & Comp.. 73.19 -1.0% Stock price decreasing
Pfizer Inc 39.38 -1.3% Stock price decreasing
Amgen Inc 177.47 -2.7% Stock price decreasing
Gilead Scien.. 62.95 -0.5% Stock price decreasing
Vertex Pharm.. 168.16 0.7% Stock price increasing
Astrazeneca .. 5,815.00 -1.7% Stock price decreasing
Novartis AG 76.41 -1.2% Stock price decreasing
Takeda PHARM.. 32.00 -3.1% Stock price decreasing
100,33,20,83,0,0,0,33,44,44
Biogen Inc 226.39 -0.3% Stock price decreasing
Roche Hldg S.. 28.54 -2.6% Stock price decreasing
100,100,100,100,100,0,0,0,0,0

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 April 2019 10:02:56
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB4 - 2019-04-21 11:02:56 - 2019-04-21 10:02:56 - 1000 - Website: OKAY